FDA Inspection 622355 — Baxalta Belgium Manufacturing SA
The FDA completed an inspection of Baxalta Belgium Manufacturing SA on October 19, 2009 in Lessines. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 19, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lessines (Belgium)